statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL

Providence, RI, March 28, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...

13 Hot Stocks to Invest in According to Wall Street Analysts

In this piece, we will take a look at the 13 hot stocks to invest in according to Wall Street analysts. If you want to skip our overview of the stock market and the latest news, then you can skip...

Ocean Biomedical Inc options imply 21.0% move in share price post-earnings

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Ocean Biomedical Inc options imply 17.8% move in share price post-earnings

Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments

PALM BEACH, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this...

Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting

Providence, RI, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company which endeavors to accelerate the development of compelling discoveries from top...

12 titoli sanitari in movimento, after-market del 23/02/2024

Titoli in rialzo
Il titolo NeuBase Therapeutics (NASDAQ:NBSE) ha osservato un incremento del 30,52% a 0,98 dollari durante la sessione after-market di venerd .
Le azioni di Ocean Biomedical...

12 acciones de salud en movimiento en la subasta de cierre del 23/02/2024

Acciones al alza
NeuBase Therapeutics (NASDAQ:NBSE) avanzaron un 31,85% para establecerse en los 0,99 d lares durante la sesi n del after-market del viernes.
Ocean Biomedical (NASDAQ:OCEA) subieron...

12 acciones de salud en movimiento en la sesi n intrad a del 23/02/2024

Acciones al alza
Ocean Biomedical (NASDAQ:OCEA) se anotaron un alza del 66,89% para establecerse en los 0,92 d lares durante la sesi n del regular del viernes.
Maravai LifeSciences (NASDAQ:MRVI...

Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria in June 2021 and is headquartered in Providence, RI.

Volume	590,550.00
52-Wk High	$7.79
52-Wk Low	$0.52

OCEA Ocean Biomedical Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals